首页> 外文期刊>Cornea >Graft survival and glaucoma outcome after simultaneous penetrating keratoplasty and ahmed glaucoma valve implant.
【24h】

Graft survival and glaucoma outcome after simultaneous penetrating keratoplasty and ahmed glaucoma valve implant.

机译:同时穿透性角膜移植术和艾哈迈德型青光眼瓣膜植入物后的移植物存活率和青光眼结果。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSETo investigate the success of corneal graft and intraocular pressure (IOP) control after simultaneous penetrating keratoplasty (PKP) and Ahmed glaucoma valve implant in patients with coexisting corneal opacity and glaucoma.METHODSA retrospective review was undertaken of adult patients at King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, who underwent simultaneous PKP and Ahmed glaucoma valve implant between January 1994 and September 1999.RESULTSTwenty-five eyes of 25 patients were included in the study. Cumulative probabilities of success by Kaplan-Meier analysis showed 92% and 50% graft success and 92% and 86% IOP control at 1 and 3 years, respectively. The main postoperative complication was graft failure in 10 of 25 cases, and the majority of those failures resulted from immunologic graft rejection and tube endothelial touch.CONCLUSIONAhmed glaucoma valve implant is effective in controlling IOP in a majority of eyes during a 3-year time span. However, corneal graft success continuesto pose challenges.
机译:目的探讨角膜混浊和青光眼并存的同时穿透角膜移植术(PKP)和艾哈迈德青光眼瓣膜植入术后角膜移植和眼内压(IOP)控制的成功。沙特阿拉伯利雅得(Riyadh)在1994年1月至1999年9月期间同时进行了PKP和艾哈迈德(Ahmed)青光眼瓣膜植入术。结果研究包括25例患者的25眼。通过Kaplan-Meier分析获得的成功累积概率分别显示,在1年和3年时,移植成功率分别为92%和50%,IOP控制率分别为92%和86%。术后主要并发症为25例中的10例移植失败,其中大部分失败是由于免疫移植排斥和管内皮接触引起的。结论改良的青光眼瓣膜植入物可有效控制3年内大部分眼的IOP 。但是,角膜移植成功仍然带来挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号